These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8077159)

  • 1. Fluoxetine-dopaminergic interaction data.
    Beasley CM
    J Clin Psychiatry; 1994 Feb; 55(2):77-9. PubMed ID: 8077159
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonergic-dopaminergic interactions and extrapyramidal function.
    Chase TN
    Adv Biochem Psychopharmacol; 1974; 11(0):377-85. PubMed ID: 4367649
    [No Abstract]   [Full Text] [Related]  

  • 3. Some derivatives of 3-amino-2-oxazolidinone influencing neurotransmission of dopamine and serotonin.
    Chilmonczyk Z; Krzywda J; Cybulski J; Iskra-Jopa J
    Pharmazie; 1997 Feb; 52(2):152-7. PubMed ID: 9122275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin-dopamine interaction: an overview.
    Esposito E; Di Matteo V; Di Giovanni G
    Prog Brain Res; 2008; 172():3-6. PubMed ID: 18772025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.
    Beasley CM; Masica DN; Heiligenstein JH; Wheadon DE; Zerbe RL
    J Clin Psychopharmacol; 1993 Oct; 13(5):312-20. PubMed ID: 8227489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence in vitro for a 5-HT link in dopaminergic neurotransmission in the anterior hypothalamic region of the rat: demonstration of a 5-HT link in dopaminergic thermoregulation? [proceedings].
    Cox B; Kerwin RW; Lee TF; Pay S; Pycock CJ
    Br J Pharmacol; 1980 Jan; 68(1):162P. PubMed ID: 6244028
    [No Abstract]   [Full Text] [Related]  

  • 7. Serotonin syndrome.
    Ivanusa Z; Hećimović H; Demarin V
    Neuropsychiatry Neuropsychol Behav Neurol; 1997 Jul; 10(3):209-12. PubMed ID: 9297715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states.
    Millan MJ; Newman-Tancredi A; Audinot V; Cussac D; Lejeune F; Nicolas JP; Cogé F; Galizzi JP; Boutin JA; Rivet JM; Dekeyne A; Gobert A
    Synapse; 2000 Feb; 35(2):79-95. PubMed ID: 10611634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2'-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission.
    Andrews AM; Murphy DL
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1432-9. PubMed ID: 8263805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An intact dopaminergic system is required for context-conditioned release of 5-HT in the nucleus accumbens of postweaning isolation-reared rats.
    Fulford AJ; Marsden CA
    Neuroscience; 2007 Oct; 149(2):392-400. PubMed ID: 17869434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat.
    Gobert A; Rivet JM; Lejeune F; Newman-Tancredi A; Adhumeau-Auclair A; Nicolas JP; Cistarelli L; Melon C; Millan MJ
    Synapse; 2000 Jun; 36(3):205-21. PubMed ID: 10819900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of dopamine and serotonin transmission in schizophrenia.
    Remington G
    Prog Brain Res; 2008; 172():117-40. PubMed ID: 18772030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tryptamine may couple dopaminergic and serotonergic transmission in the brain.
    Juorio AV; Paterson IA
    Gen Pharmacol; 1990; 21(5):613-6. PubMed ID: 2177431
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluoxetine and side effects.
    Baldessarini RJ; Marsh E
    Arch Gen Psychiatry; 1990 Feb; 47(2):191-2. PubMed ID: 2105706
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential effects of coadministration of fluoxetine and WAY-100635 on serotonergic neurotransmission in vivo: sensitivity to sequence of injections.
    Taber MT; Kinney GG; Pieschl RL; Yocca FD; Gribkoff VK
    Synapse; 2000 Oct; 38(1):17-26. PubMed ID: 10941137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent depressive state after chronic stress in rats is accompanied by HPA axis dysregulation and reduced prefrontal dopaminergic neurotransmission.
    Mizoguchi K; Shoji H; Ikeda R; Tanaka Y; Tabira T
    Pharmacol Biochem Behav; 2008 Nov; 91(1):170-5. PubMed ID: 18675292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]dopamine and [3H]serotonin release in vitro induced by electrical stimulation in A9 and A10 dopamine regions of rat brain: characterization and responsiveness to cocaine.
    Chen NH; Reith ME
    J Pharmacol Exp Ther; 1993 Oct; 267(1):379-89. PubMed ID: 8229765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of dopamine release by striatal 5-HT2C receptors.
    Alex KD; Yavanian GJ; McFarlane HG; Pluto CP; Pehek EA
    Synapse; 2005 Mar; 55(4):242-51. PubMed ID: 15668911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies.
    Di Matteo V; Di Giovanni G; Pierucci M; Esposito E
    Prog Brain Res; 2008; 172():7-44. PubMed ID: 18772026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Structural and functional organization of the cerebral dopaminergic system].
    Barishpolets VV; Fedotova IuO; Sapronov NS
    Eksp Klin Farmakol; 2009; 72(3):44-9. PubMed ID: 19642593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.